TTY Biopharm Co Ltd Cash Flow Reinvestment Rate
TTY Biopharm Co Ltd cash flow reinvestment rate. TTY Biopharm Co Ltd (4105) has a Cash Flow Reinvestment Rate of 0.27x as of March 2026, reinvesting NT$178.28 Million (capex NT$128.28 Million plus investments NT$-50.00 Million) from operating cash flow of NT$654.16 Million. Explore cash flow to debt ratio of TTY Biopharm Co Ltd to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of TTY Biopharm Co Ltd (2017–2025)
Cash flow reinvestment rate of TTY Biopharm Co Ltd from 2017 to 2025. Historical reinvestment intensity for TTY Biopharm Co Ltd across 9 annual periods. Explore TTY Biopharm Co Ltd (4105) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
TTY Biopharm Co Ltd Cash Flow Reinvestment Rate by Year (2017–2025)
TTY Biopharm Co Ltd cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for TTY Biopharm Co Ltd. For the full cash flow conversion analysis, see TTY Biopharm Co Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | NT$323.19 Million | NT$1.76 Billion | NT$150.83 Million | ▼ -5.7% |
| 2024 | 0.19x | NT$262.47 Million | NT$1.35 Billion | NT$134.29 Million | ▲ +106.5% |
| 2023 | 0.09x | NT$102.21 Million | NT$1.09 Billion | NT$99.58 Million | ▼ -31.6% |
| 2022 | 0.14x | NT$170.18 Million | NT$1.24 Billion | NT$135.50 Million | ▲ +96.1% |
| 2021 | 0.07x | NT$88.25 Million | NT$1.26 Billion | NT$74.15 Million | ▼ -92.5% |
| 2020 | 0.93x | NT$490.68 Million | NT$526.35 Million | NT$181.86 Million | ▲ +306.0% |
| 2019 | 0.23x | NT$277.82 Million | NT$1.21 Billion | NT$69.86 Million | ▼ -86.7% |
| 2018 | 1.73x | NT$1.86 Billion | NT$1.07 Billion | NT$74.09 Million | ▲ +155.8% |
| 2017 | 0.68x | NT$675.00 Million | NT$996.52 Million | NT$96.79 Million | — |